Cognitive function in the acute course of allogeneic hematopoietic stem cell transplantation for hematological malignancies.

scientific article published on 9 April 2007

Cognitive function in the acute course of allogeneic hematopoietic stem cell transplantation for hematological malignancies. is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1038/SJ.BMT.1705663
P698PubMed publication ID17417661
P5875ResearchGate publication ID6404269

P2093author name stringKoch U
Zander AR
Schirmer L
Mehnert A
Scherwath A
Schleimer B
Schulz-Kindermann F
P2860cites workThe European Organization for Research and Treatment of Cancer QLQ-C30: a quality-of-life instrument for use in international clinical trials in oncologyQ29615701
Cognitive functioning and quality of life in long-term adult survivors of bone marrow transplantation.Q33183929
Assessment of pre-treatment cognitive performance in adult bone marrow or haematopoietic stem cell transplantation patients: a comparative study.Q33214552
'Chemobrain' in breast carcinoma?: a prologueQ33980187
Neuropsychological effects of treatments for adults with cancer: a meta-analysis and review of the literatureQ35635738
Neuropsychological dysfunction associated with cancer and cancer therapies: a conceptual review of an emerging targetQ35776955
Prospective evaluation of neurological complications after allogeneic bone marrow transplantationQ43994969
Late effects of adjuvant chemotherapy on cognitive function: a follow-up study in breast cancer patientsQ44114761
Characteristics and correlates of cognitive functioning following bone marrow transplantationQ44458858
Neuropsychologic changes from before transplantation to 1 year in patients receiving myeloablative allogeneic hematopoietic cell transplantQ44976801
A metaanalysis of studies of the effects of cancer chemotherapy on various domains of cognitive functionQ46784141
Neurological and neuroradiological findings in long-term survivors of allogeneic bone marrow transplantationQ48470542
Health-related quality of life 1 year after allogeneic or autologous stem-cell transplantation: a prospective studyQ48769871
Impairment of cognitive function in women receiving adjuvant treatment for high-risk breast cancer: high-dose versus standard-dose chemotherapy.Q51099382
Psychologic and neuropsychologic impact of autologous bone marrow transplantation.Q51114762
Evaluation of the neurobehavioral functioning of patients before, during, and after bone marrow transplantation.Q51135034
Neuropsychologic impairment in adult bone marrow transplant candidatesQ52070277
The relationship of APOE genotype to neuropsychological performance in long-term cancer survivors treated with standard dose chemotherapyQ56989841
Clinical manifestations of graft-versus-host disease in human recipients of marrow from HL-A-matched sibling donorsQ70051817
Neuropsychological function in high-risk breast cancer survivors after stem-cell supported high-dose therapy versus standard-dose chemotherapy: evaluation of long-term treatment effectsQ81631400
Promotion of neurogenesis by human stem cells in high-risk breast cancer survivals after stem-cell supported high-dose therapyQ83181266
P433issue12
P407language of work or nameEnglishQ1860
P304page(s)789-799
P577publication date2007-04-09
P1433published inBone Marrow TransplantationQ4941523
P1476titleCognitive function in the acute course of allogeneic hematopoietic stem cell transplantation for hematological malignancies.
P478volume39

Reverse relations

cites work (P2860)
Q41186091A prospective evaluation of changes in brain structure and cognitive functions in adult stem cell transplant recipients
Q27013566A systematic review and meta-analysis of changes in cognitive functioning in adults undergoing hematopoietic cell transplantation
Q41923053Central nervous system complications after allogeneic hematopoietic stem cell transplantation
Q35815463Clinical predictors of cognitive function in adults treated with hematopoietic cell transplantation
Q57154398Cognitive Function and Quality of Life in Vorinostat-Treated Patients Following Matched Unrelated Donor Myeloablative Conditioning Hematopoietic Cell Transplant
Q47373380Cognitive function and its relationship to other psychosocial factors in lymphoma survivors
Q50786894Cognitive functioning in allogeneic hematopoietic stem cell transplantation recipients and its medical correlates: a prospective multicenter study.
Q37362483Consistency and construct validity of the Activity Card Sort (modified) in measuring activity resumption after stem cell transplantation.
Q36578771Developing a Risk Prediction Model for Long-Term Physical and Psychological Functioning after Hematopoietic Cell Transplantation
Q48453012Factors associated with changes in quality of life in patients undergoing allogeneic haematopoietic stem cell transplantation
Q33606151Health-related quality of life following haematopoietic cell transplantation: patient education, evaluation and intervention
Q48798780Health-related quality of life in haematopoietic stem cell transplant survivors: a qualitative study on the role of psychosocial variables and response shifts
Q48324199Investigating the temporal course, relevance and risk factors of fatigue over 5 years: a prospective study among patients receiving allogeneic HSCT.
Q37359876Mental status changes after hematopoietic stem cell transplantation
Q41995096Neurocognitive Dysfunction in Hematopoietic Cell Transplant Recipients: Expert Review From the Late Effects and Quality of Life Working Committee of the CIBMTR and Complications and Quality of Life Working Party of the EBMT.
Q48222982Neurocognitive dysfunction in hematopoietic cell transplant recipients: expert review from the late effects and Quality of Life Working Committee of the CIBMTR and complications and Quality of Life Working Party of the EBMT.
Q37901973Neurological complications of transplantation
Q36746364Physical, psychological, and social sequelae following hematopoietic stem cell transplantation: a review of the literature.
Q33949546Predictors of health-related quality of life in patients treated with auto- and allo-SCT for hematological malignancies
Q91345168Predictors of the trajectory of cognitive functioning in the first 6 months after allogeneic hematopoietic stem cell transplantation
Q41604163Prospective assessment of white matter integrity in adult stem cell transplant recipients
Q35023468Prospective neurocognitive function over 5 years after allogeneic hematopoietic cell transplantation for cancer survivors compared with matched controls at 5 years
Q38203303Psychiatric and psychosocial challenges in patients undergoing haematopoietic stem cell transplants
Q41333675Quality of Life and Psychopathology in Adults Who Underwent Hematopoietic Stem Cell Transplantation (HSCT) in Childhood: A Qualitative and Quantitative Analysis.
Q37262503Quality of life after allogeneic hematopoietic cell transplantation
Q37878252Quality of life in patients before and after haematopoietic stem cell transplantation measured with the European Organization for Research and Treatment of Cancer (EORTC) Quality of Life Core Questionnaire QLQ-C30.
Q34729742Symptoms and quality of life in diverse patients undergoing hematopoietic stem cell transplantation
Q33914006The symptom experience in the first 100 days following allogeneic hematopoietic stem cell transplantation (HSCT).
Q56979005What Do Transplant Physicians Think About Palliative Care? A National Survey Study

Search more.